Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 6 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $30.00 (7.53% upside)

Current Analysts' Coverage Summary for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/27/2015Citigroup Inc.Initiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2015MizuhoInitiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2015ZacksReiterated RatingNeutral -> Neutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
1/21/2015Leerink SwannUpgradeMarket Perform -> Outperform$24.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2014Credit Suisse Group AGUpgradeNeutral -> Outperform$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies Group LLCDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/27/2013GuggenheimInitiated CoverageMarket Perform -> Buy$39.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/27/2013 forward)